SCHEMBL6907589

SCHEMBL6907589

O=C(Cl)C=Cc1ccccc1C=CC(=O)Cl

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NFKB1 P19838 3/20 0.50
NFE2L2 Q16236 3/20 0.50
JUN P05412 1/20 0.50
CA1 P00915 1/20 0.48
CA2 P00918 1/20 0.48
CA4 P22748 1/20 0.48
HSD11B1 P28845 1/20 0.48
HDAC1 Q13547 1/20 0.47
HDAC8 Q9BY41 1/20 0.47
HDAC6 Q9UBN7 1/20 0.47
GSR P00390 1/20 0.47
MAPT P10636 7/20 0.47
LMNA P02545 2/20 0.47
NPC1 O15118 2/20 0.45
RAB9A P51151 2/20 0.45
BCHE P06276 1/20 0.44
GUSB P08236 1/20 0.44
TFEB P19484 1/20 0.44
MAOB P27338 1/20 0.43
MAPK1 P28482 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30390592 0.87 HDAC1 (0.65) NFKB1HDAC1HDAC8HDAC6GSR
SCHEMBL1569435 0.87 HDAC1 (0.65) NFKB1HDAC1HDAC8HDAC6GSR
SCHEMBL3321477 0.87 NFKB1 (0.70) NFKB1NFE2L2JUNCA1CA2
SCHEMBL3321487 0.87 NFKB1 (0.70) NFKB1NFE2L2JUNCA1CA2
SCHEMBL1569438 0.87 HDAC1 (0.65) NFKB1HDAC1HDAC8HDAC6GSR
SCHEMBL6421789 0.85 ALDH1A1 (0.48) NFKB1NFE2L2JUNCA1CA2
SCHEMBL6583886 0.85 NFE2L2 (0.58) NFE2L2MAPTLMNANPC1RAB9A
SCHEMBL9780865 0.85 HSD11B1 (0.71) NFKB1NFE2L2JUNCA1CA2
SCHEMBL7069601 0.85 ALDH1A1 (0.48) NFKB1NFE2L2JUNCA1CA2
SCHEMBL9780869 0.85 HSD11B1 (0.71) NFKB1NFE2L2JUNCA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6689899-B2 HYDROGENATION OF THE CORRESPONDING DINITRO COMPOUNDS KANEGAFUCHI KAGAKU KOGYO KABUSHIKI KAISHA (JP) 2004-02-10 US disclosed
US-20020019558-A1 Diamine and acid anhydride KANEGAFUCHI KAGAKU KOGYO KABUSHIKI KAISHA (JP) 2002-02-14 US disclosed
US-6303742-B1 CHARACTERIZED BY A CINNAMOYL GROUP OR A DERIVED CINNAMOYL GROUP INCORPORATED THEREIN AND BY PHOTO-REACTIVITY AND HEAT-REACTIVITY WHICH ARE INHERENT IN THE CINNAMOYL GROUP. KANEKAFUCHI KAGAKU KOGYO KABUSHIKI KAISHA (JP) 2001-10-16 US disclosed
US-6294593-B1 COMBINING HOST POLYMER WITH GUEST CROSSLINIKING AGENT; EXPOSING COMBINED HOST POLYMER AND GUEST CROSSLINKING AGENT TO ELECTRIC FIELD TO POLE SECOND ORDER NONLINEAR OPTICAL COMPONENT OF POLYMER; EXPOSING TO ELECTROMAGNETIC RADIATION UNIVERSITY OF MASSACHUSETTS LOWELL 2001-09-25 US disclosed
EP-0045694-B1 TWO-SHEET DIFFUSION TRANSFER PHOTOGRAPHIC ASSEMBLAGES EASTMAN KODAK COMPANY (a New Jersey corporation) (US) 1985-05-15 EP disclosed
EP-0045693-B1 PHOTOGRAPHIC ELEMENT FOR TWO-SHEET DIFFUSION TRANSFER PHOTOGRAPHY EASTMAN KODAK COMPANY (a New Jersey corporation) (US) 1985-04-10 EP disclosed
US-4346160-A OVERCAOTING PREVENTS PREMATURE DELAMINATION EASTMAN KODAK COMPANY (US) 1982-08-24 US disclosed
EP-0045693-A2 Photographic element for two-sheet diffusion transfer photography EASTMAN KODAK COMPANY (a New Jersey corporation) (US) 1982-02-10 EP disclosed
EP-0045694-A2 Two-sheet diffusion transfer photographic assemblages EASTMAN KODAK COMPANY (a New Jersey corporation) (US) 1982-02-10 EP disclosed
US-4298682-A PREVENTION OF SPONTANEOUS DELAMINATION EASTMAN KODAK COMPANY (US) 1981-11-03 US disclosed
US-4297432-A CONTAINING A VINYLIDENE CHLORIDE POLYMERIC LAYER, AN ANIONIC POLYESTER LAYER AND A CATIONIC ACRYLIC ESTER OR AMIDE POLYMER LAYER EASTMAN KODAK COMPANY (US) 1981-10-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020019558-A1 Diamine and acid anhydride CA1, ASIC1, CA4 NFKB1 2872/4885NFE2L2 1523/4885JUN 3136/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.